Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line Helicobacter pylori eradication: a real-world evidence study

CONCLUSIONS: The bismuth add-on increased the first-line H. pylori eradication rate of 2-week TPZ-based triple therapy.PMID:38459869 | DOI:10.1080/14787210.2024.2329251
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Authors: Source Type: research